Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Aspira Women's Health Inc.AWH · Entity 7871 | Director | July 25, 2023 | December 28, 2023 |
| BICYCLE THERAPEUTICS PLCBCYC · Entity 5993 | Director | January 02, 2024 | January 04, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Aspira Women's Health Inc.
Report date July 25, 2023 · Filed December 28, 2023 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 41,620 |
Reported balance
After 2023-08-28 transaction · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · 2023-08-28 · Grant · Acquired 7,045 · Balance 41,620 F1: The shares of common stock represent restricted stock units with contingent right to receive one share of common stock. The restricted stock units vest 1/3 on each of June 1, 2023, September 1, 2023 and December 1, 2023. F2: This report is being filed to correct the grant date of the restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares of common stock represent restricted stock units with contingent right to receive one share of common stock. The restricted stock units vest 1/3 on each of June 1, 2023, September 1, 2023 and December 1, 2023.
F2: This report is being filed to correct the grant date of the restricted stock units.
BICYCLE THERAPEUTICS PLC
Report date January 02, 2024 · Filed January 04, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 16,750 |
Reported balance
After 2024-01-02 transaction · row 1
1 source rowRow 1 · 2024-01-02 · Grant · Acquired 6,000 · Balance 16,750 F1: Represents a restricted stock unit ("RSU") award. The RSUs shall vest in four equal installments on March 15, 2024, June 15, 2024, September 15, 2024 and December 15, 2024. F2: Each RSU represents a contingent right to receive one ordinary share. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $18.08 · Expires 2034-01-02 | Direct | 12,000 |
Reported balance
After 2024-01-02 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2024-01-02 · Grant · Acquired 12,000 · Balance 12,000 F3: This option shall vest in four equal installments on March 15, 2024, June 15, 2024, September 15, 2024 and December 15, 2024. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a restricted stock unit ("RSU") award. The RSUs shall vest in four equal installments on March 15, 2024, June 15, 2024, September 15, 2024 and December 15, 2024.
F2: Each RSU represents a contingent right to receive one ordinary share.
F3: This option shall vest in four equal installments on March 15, 2024, June 15, 2024, September 15, 2024 and December 15, 2024.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 02, 2024 Filed Jan 4, 2024 18:31 UTC | BICYCLE THERAPEUTICS PLC BCYC · Entity 5993 | GrantStock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $18.08 | $0.00 |
DisclosureSEC source: 0001209191-24-000883 · doc4.xml · derivative · entry 2 Jordan Veronica GH · CIK 0001381123 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,000 Underlying: Ordinary Shares · 12,000 shares Expires 2034-01-02 F3 · derivative.exercise_date: This option shall vest in four equal installments on March 15, 2024, June 15, 2024, September 15, 2024 and December 15, 2024. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 18:31 UTC | BICYCLE THERAPEUTICS PLC BCYC · Entity 5993 | GrantOrdinary Shares | 6,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-24-000883 · doc4.xml · nonDerivative · entry 1 Jordan Veronica GH · CIK 0001381123 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,750 F1 · shares: Represents a restricted stock unit ("RSU") award. The RSUs shall vest in four equal installments on March 15, 2024, June 15, 2024, September 15, 2024 and December 15, 2024. F2 · price: Each RSU represents a contingent right to receive one ordinary share. Read SEC document |
| August 28, 2023 Filed Dec 28, 2023 00:07 UTC Amendment | Aspira Women's Health Inc. AWH · Entity 7871 | GrantCommon Stock | 7,045 | $0.00 | $0.00 |
DisclosureSEC source: 0001381123-23-000005 · primary_doc.xml · nonDerivative · entry 1 Jordan Veronica GH · CIK 0001381123 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,620 F1 · shares: The shares of common stock represent restricted stock units with contingent right to receive one share of common stock. The restricted stock units vest 1/3 on each of June 1, 2023, September 1, 2023 and December 1, 2023. F2 · shares: This report is being filed to correct the grant date of the restricted stock units. Read SEC document |
| July 25, 2023 Filed Jul 26, 2023 20:55 UTC | Aspira Women's Health Inc. AWH · Entity 7871 | GrantCommon stock | 7,045 | $0.00 | $0.00 |
DisclosureSEC source: 0001381123-23-000004 · primary_doc.xml · nonDerivative · entry 1 Jordan Veronica GH · CIK 0001381123 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,620 F1 · shares: The shares of common stock represent restricted stock units with contingent right to receive one share of common stock. The restricted stock units vest 1/3 on each of June 1, 2023, September 1, 2023 and December 1, 2023. Read SEC document |
| July 24, 2023 Filed Jul 24, 2023 22:58 UTC | Aspira Women's Health Inc. AWH · Entity 7871 | PurchaseCommon stock | 3,769 | $3.98 | $15,000.62 |
DisclosureSEC source: 0001381123-23-000003 · primary_doc.xml · nonDerivative · entry 1 Jordan Veronica GH · CIK 0001381123 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,575 Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 21:25 UTC | Aspira Women's Health Inc. AWH · Entity 7871 | GrantEmployee Stock Option (Right to Buy) · Derivative | 6,849 | $0.00 Strike: $2.99 | $0.00 |
DisclosureSEC source: 0001381123-23-000002 · primary_doc.xml · derivative · entry 2 Jordan Veronica GH · CIK 0001381123 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,849 Underlying: Common Stock · 6,849 shares Expires 2033-06-01 F2 · derivative.exercise_date: The employee stock option will vest in the amount of 2,731 shares on June 1, 2023, 2,059 shares on September 1, 2023 and 2,059 shares on December 1, 2023. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 21:25 UTC | Aspira Women's Health Inc. AWH · Entity 7871 | GrantCommon Stock | 4,385 | $0.00 | $0.00 |
DisclosureSEC source: 0001381123-23-000002 · primary_doc.xml · nonDerivative · entry 1 Jordan Veronica GH · CIK 0001381123 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,806 F1 · shares: 1,749 of the restricted stock units will vest on June 1, 2023, 1,318 of the restricted stock units will vest on September 1, 2023 and 1,318 of the restricted stock units will vest on December 1, 2023. Read SEC document |
| February 09, 2023 Filed Feb 14, 2023 01:45 UTC | Aspira Women's Health Inc. AWH · Entity 7871 | GrantEMPLOYEE STOCK OPTION (RIGHT TO BUY) · Derivative | 196,914 | $0.00 Strike: $0.57 | $0.00 |
DisclosureSEC source: 0001381123-23-000001 · primary_doc.xml · derivative · entry 2 Jordan Veronica GH · CIK 0001381123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 196,914 Underlying: COMMON STOCK · 196,914 shares Expires 2033-02-09 F2 · derivative.exercise_date: The employee stock option will vest in four equal installments on April 1, 2023, June 1, 2023, September 1, 2023 and December 1, 2023. Read SEC document |
| February 09, 2023 Filed Feb 14, 2023 01:45 UTC | Aspira Women's Health Inc. AWH · Entity 7871 | GrantCOMMON STOCK | 35,225 | $0.00 | $0.00 |
DisclosureSEC source: 0001381123-23-000001 · primary_doc.xml · nonDerivative · entry 1 Jordan Veronica GH · CIK 0001381123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 396,400 F1 · shares: The shares of common stock represent restricted stock units with contingent right to receive one share of common stock. The restricted stock units will vest on April 1, 2023. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 21:32 UTC | BICYCLE THERAPEUTICS PLC BCYC · Entity 5993 | GrantStock Option (right to buy) · Derivative | 11,500 | $0.00 Strike: $29.60 | $0.00 |
DisclosureSEC source: 0001209191-23-002223 · doc4.xml · derivative · entry 2 Jordan Veronica GH · CIK 0001381123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,500 Underlying: Ordinary Shares · 11,500 shares Expires 2033-01-03 F3 · derivative.exercise_date: This option shall vest in four equal installments on March 15, 2023, June 15, 2023, September 15, 2023 and December 15, 2023. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 21:32 UTC | BICYCLE THERAPEUTICS PLC BCYC · Entity 5993 | GrantOrdinary Shares | 5,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-002223 · doc4.xml · nonDerivative · entry 1 Jordan Veronica GH · CIK 0001381123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,750 F1 · shares: Represents a restricted stock unit ("RSU") award. The RSUs shall vest in four equal installments on March 15, 2023, June 15, 2023, September 15, 2023 and December 15, 2023. F2 · price: Each RSU represents a contingent right to receive one ordinary share. Read SEC document |
| March 31, 2022 Filed Apr 5, 2022 00:44 UTC | Aspira Women's Health Inc. awh · Entity 7871 | GrantEmployee Stock Option (Right to Buy) · Derivative | 93,977 | $0.00 Strike: $1.04 | $0.00 |
DisclosureSEC source: 0001381123-22-000001 · primary_doc.xml · derivative · entry 3 Jordan Veronica GH · CIK 0001381123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,977 Underlying: Common Stock · 93,977 shares Expires 2032-03-31 F2 · derivative.exercise_date: The employee stock option will vest in four equal installments on April 1, 2022, June 1, 2022, September 1, 2022 and December 1, 2022. Read SEC document |
| March 31, 2022 Filed Apr 5, 2022 00:44 UTC | Aspira Women's Health Inc. awh · Entity 7871 | GrantCommon Stock | 11,516 | $0.00 | $0.00 |
DisclosureSEC source: 0001381123-22-000001 · primary_doc.xml · nonDerivative · entry 2 Jordan Veronica GH · CIK 0001381123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 361,175 F1 · shares: The restricted stock units will vest in four equal installments on April 1, 2022, June 1, 2022, September 1, 2022 and December 1, 2022. Read SEC document |
| March 31, 2022 Filed Apr 5, 2022 00:44 UTC | Aspira Women's Health Inc. awh · Entity 7871 | GrantCommon Stock | 62,140 | $0.00 | $0.00 |
DisclosureSEC source: 0001381123-22-000001 · primary_doc.xml · nonDerivative · entry 1 Jordan Veronica GH · CIK 0001381123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 349,659 F1 · shares: The restricted stock units will vest in four equal installments on April 1, 2022, June 1, 2022, September 1, 2022 and December 1, 2022. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 17:42 UTC | BICYCLE THERAPEUTICS PLC BCYC · Entity 5993 | GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $60.87 | $0.00 |
DisclosureSEC source: 0001209191-22-001867 · doc4.xml · derivative · entry 2 Jordan Veronica GH · CIK 0001381123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Ordinary Shares · 10,000 shares Expires 2032-01-03 F3 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 17:42 UTC | BICYCLE THERAPEUTICS PLC BCYC · Entity 5993 | GrantOrdinary Shares | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-001867 · doc4.xml · nonDerivative · entry 1 Jordan Veronica GH · CIK 0001381123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 F1 · shares: Represents a restricted stock unit ("RSU") award. The RSUs are fully vested. F2 · price: Each RSU represents a contingent right to receive one ordinary share. Read SEC document |
| March 19, 2021 Filed Mar 23, 2021 21:25 UTC | Aspira Women's Health Inc. AWH · Entity 7871 | GrantCommon Stock | 16,442 | $0.00 | $0.00 |
DisclosureSEC source: 0001381123-21-000001 · primary_doc.xml · nonDerivative · entry 1 Jordan Veronica GH · CIK 0001381123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 287,519 F1 · shares: The shares of common stock represent restricted stock units with contingent right to receive one share of common stock of Aspira Women's Health Inc. for each restricted stock unit. The restricted stock units will vest in four equal installments on April 1, 2021, June 1, 2021, September 1, 2021 and December 1, 2021. F2 · balance_after: Total reflects the adjustment of 17,617 shares of common stock previously reported as part of a restricted stock unit grant made on March 19, 2020. Read SEC document |
| January 04, 2021 Filed Jan 5, 2021 17:29 UTC | BICYCLE THERAPEUTICS PLC BCYC · Entity 5993 | GrantStock Option (right to buy) · Derivative | 19,000 | $0.00 Strike: $17.95 | $0.00 |
DisclosureSEC source: 0001209191-21-001341 · doc4.xml · derivative · entry 1 Jordan Veronica GH · CIK 0001381123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,000 Underlying: Ordinary Shares · 19,000 shares Expires 2031-01-04 Read SEC document |
| June 05, 2020 Filed Jun 10, 2020 00:25 UTC | Aspira Women's Health Inc. VRML · Entity 7871 | OtherWarrants to acquire Common Stock · Derivative | 5,021 | $0.00 Strike: $1.80 | $0.00 |
DisclosureSEC source: 0001562762-20-000219 · certent-form4.xml · derivative · entry 2 Jordan Veronica GH · CIK 0001381123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,021 shares Expires 2020-06-09 Read SEC document |
| June 05, 2020 Filed Jun 10, 2020 00:25 UTC | Aspira Women's Health Inc. VRML · Entity 7871 | OtherCommon Stock | 5,021 | $1.80 | $9,037.80 |
DisclosureSEC source: 0001562762-20-000219 · certent-form4.xml · nonDerivative · entry 1 Jordan Veronica GH · CIK 0001381123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 288,694 Read SEC document |
| March 19, 2020 Filed Mar 23, 2020 21:33 UTC | Aspira Women's Health Inc. VRML · Entity 7871 | GrantEMPLOYEE STOCK OPTION (RIGHT TO BUY) · Derivative | 122,537 | $0.00 Strike: $0.68 | $0.00 |
DisclosureSEC source: 0001562762-20-000125 · certent-form4.xml · derivative · entry 2 Jordan Veronica GH · CIK 0001381123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,537 Underlying: COMMON STOCK · 122,537 shares Expires 2030-03-19 F2 · derivative.exercise_date: The employee stock option will vest in four equal installments on April 1, 2020, June 1, 2020, September 1, 2020 and December 1, 2020. Read SEC document |
| March 19, 2020 Filed Mar 23, 2020 21:33 UTC | Aspira Women's Health Inc. VRML · Entity 7871 | GrantCommon Stock | 70,467 | $0.00 | $0.00 |
DisclosureSEC source: 0001562762-20-000125 · certent-form4.xml · nonDerivative · entry 1 Jordan Veronica GH · CIK 0001381123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 283,673 F1 · shares: The shares of common stock represent restricted stock units with contingent right to receive one share of common stock of Vermillion, Inc. for each restricted stock unit. The restricted stock units will vest in four equal installments on April 1, 2020, June 1, 2020, September 1, 2020 and December 1, 2020. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 16:56 UTC | BICYCLE THERAPEUTICS PLC BCYC · Entity 5993 | GrantStock Option (right to buy) · Derivative | 16,000 | $0.00 Strike: $9.82 | $0.00 |
DisclosureSEC source: 0001209191-20-001930 · doc4.xml · derivative · entry 1 Jordan Veronica GH · CIK 0001381123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,000 Underlying: Ordinary Shares · 16,000 shares Expires 2030-01-02 Read SEC document |
| December 17, 2019 Filed Dec 19, 2019 18:04 UTC | BICYCLE THERAPEUTICS PLC BCYC · Entity 5993 | GrantStock Option (right to buy) · Derivative | 32,000 | $0.00 Strike: $8.30 | $0.00 |
DisclosureSEC source: 0001209191-19-061400 · doc4.xml · derivative · entry 1 Jordan Veronica GH · CIK 0001381123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,000 Underlying: Ordinary Shares · 32,000 shares Expires 2029-12-17 F1 · derivative.exercise_date: The shares underlying this option shall vest in 36 equal monthly installments at the end of each calendar month, commencing on October 23, 2019. Read SEC document |
| March 26, 2019 Filed Mar 28, 2019 22:54 UTC | Aspira Women's Health Inc. VRML · Entity 7871 | GrantEMPLOYEE STOCK OPTION (RIGHT TO BUY) · Derivative | 98,907 | $0.00 Strike: $1.29 | $0.00 |
DisclosureSEC source: 0001562762-19-000083 · certent-form4.xml · derivative · entry 2 Jordan Veronica GH · CIK 0001381123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,907 Underlying: COMMON STOCK · 98,907 shares Expires 2029-03-26 F2 · derivative.exercise_date: The employee stock option will vest in four equal installments on April 1, 2019, June 1, 2019, September 1, 2019 and December 1, 2019. Read SEC document |
| March 26, 2019 Filed Mar 28, 2019 22:54 UTC | Aspira Women's Health Inc. VRML · Entity 7871 | GrantCommon Stock | 37,689 | $0.00 | $0.00 |
DisclosureSEC source: 0001562762-19-000083 · certent-form4.xml · nonDerivative · entry 1 Jordan Veronica GH · CIK 0001381123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 213,206 F1 · shares: The shares of common stock represent restricted stock units with contingent right to receive one share of common stock of Vermillion, Inc. for each restricted stock unit. The restricted stock units will vest in four equal installments on April 1, 2019, June 1, 2019, September 1, 2019 and December 1, 2019. Read SEC document |
| April 13, 2018 Filed Apr 17, 2018 20:39 UTC | Aspira Women's Health Inc. VRML · Entity 7871 | GrantCommon Stock | 79,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001562762-18-000133 · certent-form4.xml · nonDerivative · entry 1 Jordan Veronica GH · CIK 0001381123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,517 F1 · shares: The shares of common stock represent restricted stock units with contingent right to receive one share of common stock of Vermillion, Inc. for each restricted stock unit. 50% of the restricted stock units will vest on June 1, 2018, 25% of the restricted stock units will vest on September 1, 2018 and 25% of the restricted stock units will vest on December 1, 2018. Read SEC document |
| March 23, 2017 Filed Mar 27, 2017 20:46 UTC | Aspira Women's Health Inc. VRML · Entity 7871 | GrantCommon Stock | 25,602 | $0.00 | $0.00 |
DisclosureSEC source: 0000926617-17-000019 · certent-form4.xml · nonDerivative · entry 1 Jordan Veronica GH · CIK 0001381123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,917 F1 · shares: The shares of common stock represent restricted stock units with contingent right to receive one share of common stock of Vermillion, Inc. for each restricted stock unit. 50% of the restricted stock units will vest on June 1, 2017, 25% of the restricted stock units will vest on September 1, 2017 and 25% of the restricted stock units will vest on December 1, 2017. Read SEC document |
| February 13, 2017 Filed Feb 15, 2017 22:08 UTC | Aspira Women's Health Inc. VRML · Entity 7871 | PurchaseWarrants (Right to buy) · Derivative | 5,021 | $0.13 Strike: $1.80 | $627.63 |
DisclosureSEC source: 0000926617-17-000008 · certent-form4.xml · derivative · entry 2 Jordan Veronica GH · CIK 0001381123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,021 Underlying: Common Stock · 5,021 shares Expires 2022-02-17 Read SEC document |
| February 13, 2017 Filed Feb 15, 2017 22:08 UTC | Aspira Women's Health Inc. VRML · Entity 7871 | PurchaseCommon Stock, par value $0.001 | 6,695 | $1.40 | $9,373.00 |
DisclosureSEC source: 0000926617-17-000008 · certent-form4.xml · nonDerivative · entry 1 Jordan Veronica GH · CIK 0001381123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,315 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.